Description
Ibrutinib is a medication primarily used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. It belongs to a class of drugs known as Bruton’s tyrosine kinase (BTK) inhibitors, which work by blocking the activity of BTK, a protein involved in the growth and survival of cancer cells. Ibrutinib is typically taken orally in capsule or tablet form.
Theresa (verified owner) –
Delivery was incredibly fast, arriving much sooner than expected. The quick turnaround was much appreciated.
Velma (verified owner) –
Delivery was incredibly fast for my order of product. The efficiency was a pleasant surprise.
Charity (verified owner) –
The packaging for my product was secure and well-done. Everything arrived in perfect condition.